Regencell Bioscience Holdings reported total assets of $14.73M and total liabilities of $1.38M for the quarter ended Jun 2026, up 16.7% year over year. This balance sheet covers 8 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Jun2020 | Jun2021 | Jun2022 | Jun2023 | Jun2024 | Jun2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Current Assets | ||||||||
| Cash & EquivalentsCash & Equiv. | 0.39M | 0.06M | 6.42M | 1.56M | 2.96M | 2.42M | 2.36M | 14.19M |
| Short-term InvestmentsInvestments (Current) | 10.00M | 10.00M | 5.00M | 2.48M | ||||
| Cash & Current Investments | 0.39M | 0.06M | 16.42M | 11.56M | 7.96M | 4.90M | 2.36M | 14.19M |
| Prepaid Assets | 0.01M | 0.03M | 0.06M | 0.15M | 0.01M | 0.03M | ||
| Current Assets | 0.39M | 0.07M | 16.44M | 11.62M | 8.11M | 4.90M | 2.36M | 14.22M |
| Non-Current Assets | ||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.11M | 0.08M | 0.71M | 0.44M | 0.14M | 0.22M | 0.18M | 0.14M |
| Long-Term Deferred Tax | 0.75M | 0.45M | 0.08M | 0.54M | 0.39M | 0.30M | ||
| Other Non-Current Assets | 0.02M | 0.19M | 0.11M | 0.11M | 0.10M | 0.09M | 0.09M | 0.08M |
| Non-Current Assets | 0.13M | 0.27M | 1.57M | 1.00M | 0.32M | 0.85M | 0.66M | 0.51M |
| Assets | 0.51M | 0.34M | 18.02M | 12.62M | 8.44M | 5.76M | 3.01M | 14.73M |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Notes Payables | 3.25M | 0.02M | 0.01M | 0.01M | 0.00M | 106.00 | 0.01M | |
| Payables | 3.25M | 0.02M | 0.01M | 0.01M | 0.00M | 106.00 | 0.01M | |
| Accumulated Expenses | 0.10M | 0.57M | 0.15M | 0.16M | 0.13M | 0.35M | 1.41M | 1.07M |
| Other Accumulated Expenses | 0.08M | 0.02M | 0.44M | 0.06M | 0.00M | 0.01M | 0.24M | |
| Short term Debt | 3.07M | 0.43M | ||||||
| Total Current Liabilities | 3.16M | 4.34M | 0.58M | 0.61M | 0.19M | 0.66M | 1.67M | 1.32M |
| Non-Current Liabilities | ||||||||
| Minority Interest | 0.02M | -0.04M | ||||||
| Operating Leases | 0.36M | 0.03M | 0.03M | 0.23M | 0.13M | 0.06M | ||
| Total Liabilities | 3.16M | 4.34M | 0.94M | 0.63M | 0.22M | 0.90M | 1.79M | 1.38M |
| Shareholder's Equity | ||||||||
| Total Debt | 3.07M | 3.68M | 0.02M | 0.01M | 0.01M | 0.00M | 106.00 | 0.01M |
| Common Equity | -2.65M | -4.00M | 17.08M | 11.99M | 8.22M | 4.86M | 1.22M | 13.35M |
| Liabilities and Shareholders Equity | 0.51M | 0.34M | 18.02M | 12.62M | 8.44M | 5.76M | 3.01M | 14.73M |
| Retained Earnings | -2.65M | -4.00M | -11.44M | -17.32M | -21.62M | -25.20M | -30.52M | -36.90M |
Pull Regencell Bioscience Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=RGC&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "RGC", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=RGC&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();